🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a single-center, single-arm, prospective phase II clinical st...
Status
Completed
Location
Tianjin Cancer Hospital
Start Date
2021-01-01
Trial ID
NCT04903652
Treatments Being Tested
The purpose of this study is to identify the highest tolerable dose of pyro...
Status
Unknown
Location
Multiple Locations
Start Date
2019-08-15
Trial ID
NCT03997539
Treatments Being Tested
Pyrotinib is an oral tyrosine kinase inhibitor targeting both HER1, HER2 an...
Status
Unknown
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2018-12-22
Trial ID
NCT03933982
Treatments Being Tested
This is a prospective, no interventional, single arm cohort study, which ai...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2022-03-16
Trial ID
NCT05856383
Treatments Being Tested
Pyrotinib is an oral tyrosine kinase inhibitor targeting both HER-1 and HER...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-09-15
Trial ID
NCT05346861
Treatments Being Tested
This study is a single-arm, prospective, open label clinical study for eval...
Status
Unknown
Location
Multiple Locations
Start Date
2019-06-01
Trial ID
NCT03947242
Treatments Being Tested
This is a real world study to evaluate the efficacy and safety of inetetamb...
Status
Unknown
Location
Jiangsu Provincial People's Hospital
Start Date
2020-01-01
Trial ID
NCT05764941
Treatments Being Tested
To evaluate the patterns and treatment outcomes of pyrotinib plus vinorelbi...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2018-05-15
Trial ID
NCT04517305
HER2-targeted therapy after the failure of trastuzumab treatment has become...
Status
Unknown
Location
Sun Yat Sen Memorial Hospital，Sun Yat sen University
Start Date
2020-09-09
Trial ID
NCT04681911
Treatments Being Tested
The purpose of this study is to identify the highest tolerable dose of pyro...
Status
Unknown
Location
Zhang Jingmin
Start Date
2020-05-22
Trial ID
NCT04605575
Treatments Being Tested